Effects of prednisone acetate on renal function, renal inflammation and AMPK/SIRT1 signaling pathway in diabetic nephropathy rats

doi:10.16352/j.issn.1001-6325.2022.02.006

Abstract

Abstract: Objective To explore the effect of prednisone acetate on renal function, renal inflammatory response and AMP-activated protein kinase (AMPK)/silent information regulator 1 (SIRT1) signaling pathway in diabetic nephropathy (DN) rats. Methods Twelve rats were randomly selected as the control group, and the remaining rats were given high-sugar and high-fat diet supplemented with intraperitoneal injection of streptozotocin (STZ) to construct a DN rat model. The successful model rats were randomly divided into model group, prednisone acetate low (6.25 mg/kg), high (12.5 mg/kg) dose groups, prednisone acetate + CC group (prednisone acetate 12.5 mg/kg+AMPK inhibitor compound C 0.2 mg/kg), with 12 animals in each group. Each group was given corresponding treatment, once a day for 4 weeks. The general state of rats was observed, and the fasting blood glucose (FBG), 24-hour urine microalbumin (U-mAlb), blood creatinine (SCr), blood urea nitrogen (BUN), serum interleukin-6 (IL-6), interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) were detected; the pathological changes of renal tissue were observed with hematoxylin eosin (HE) staining and periodate schiff (PAS) staining; The expression of proteins related to the renal tissue AMPK/SIRT1 signaling pathway was detected with Western blot. Results Prednisone acetate can improve the general state of DN rats, reduce FBG, 24 h U-mAlb, serum SCr, BUN, IL-1β, IL-6 and TNF-α levels, and renal tissue acetylation nuclear factor-κB p65 (ac-NF-κB p65)/NF-κB p65 and monocyte chemotactic protein-1 (MCP-1) protein expression (P＜0.05), increase phosphorylated AMPK(p-AMPK)/AMPK and SIRT1 protein expression (P＜0.05), improve kidney disease; compound C could significantly weaken the protective effect of prednisone acetate on DN rats. Conclusions Prednisone acetate can reduce renal inflammatory response and protect renal function in DN rats. Its mechanism may be related to the activation of AMPK/SIRT1 pathway to inhibit the activation of NF-κB.

Key words: prednisone acetate, diabetic nephropathy, inflammatory reaction, AMP-activated protein kinase/silent information regulator 1 signaling pathway(AMPK/SIRT1)

CLC Number:

DENG Jiu-hong, ZHENG Chao, WANG Sheng-yao, WANG Xin-yi. Effects of prednisone acetate on renal function, renal inflammation and AMPK/SIRT1 signaling pathway in diabetic nephropathy rats[J]. Basic & Clinical Medicine, 2022, 42(2): 243-248.

References

[1]Nagib AM, Elsayed Matter Y, Gheith OA, et al. Diabetic nephropathy following posttransplant diabetes mellitus[J]. Exp Clin Transplant, 2019, 17:138-146.
[2]郭红宝, 刘友霞, 贾俊亚, 等. miR-451通过Akt负向调控糖尿病肾病患者组织上皮间质转分化[J]. 基础医学与临床, 2020, 40:469-472.
[3]Xue W, Mao J, Chen Q, et al. Mogroside IIIE alleviates high glucose-induced inflammation, oxidative stress and apoptosis of podocytes by the activation of AMPK/SIRT1 signaling pathway[J]. Diabetes Metab Syndr Obes, 2020, 13:3821-3830.
[4]Xu J, Wang G, Tan S, et al. The clinical effect of Prednisone in combination with Mycophenolate mofetil on idiopathic thrombocytopenic purpura (ITP) and its influence on the level of peripheral blood T lymphocytes and NK lymphocytes[J]. Saudi J Biol Sci, 2019, 26:2108-2112.
[5]王利伟. 吗替麦考酚酯胶囊联合醋酸泼尼松片治疗狼疮性肾炎患者的临床疗效[J]. 医学理论与实践, 2021, 34:808-810.
[6]董君宇, 王勃, 贾玉涛, 等. 缬沙坦胶囊联合醋酸泼尼松片治疗原发性肾病综合征患儿的疗效及对肾功能及炎性因子的影响[J]. 现代生物医学进展, 2021, 21:307-310.
[7]王静. 雷公藤多苷联合小剂量醋酸泼尼松片治疗特发膜性肾病患者的疗效评价[J]. 中国药物与临床, 2021, 21:604-606.
[8]Li F, Chen Y, Li Y, et al. Geniposide alleviates diabetic nephropathy of mice through AMPK/SIRT1/NF-κB pathway[J]. Eur J Pharmacol, 2020, 886:173-179.
[9]杨坤宝, 庞宗然, 白颖慧, 等. 藏族药灰兜巴下调Nox4表达减轻糖尿病肾病大鼠肾脏氧化应激损伤[J]. 中国实验方剂学杂志, 2020, 26:84-90.
[10]丁凡, 李宏伟, 欧阳勤, 等. 二甲双胍激活AMPK/mTOR通路上调阴茎海绵体自噬增强老年ED大鼠勃起功能[J]. 第三军医大学学报, 2020, 42:1109-1115.
[11]Lu Q, Chen YB, Yang H, et al. Inactivation of TSC1 promotes epithelial-mesenchymal transition of renal tubular epithelial cells in mouse diabetic nephropathy[J]. Acta Pharmacol Sin, 2019, 40:1555-1567.
[12]Wang Y, Cui J, Liu M, et al. Schisandrin C attenuates renal damage in diabetic nephropathy by regulating macrophage polarization[J]. Am J Transl Res, 2021, 13:210-222.
[13]Juszczak F, Caron N, Mathew AV, et al. Critical role for AMPK in metabolic disease-induced chronic kidney disease[J]. Int J Mol Sci, 2020, 21:7994-8016.
[14]Han X, Dong XX, Shi MY, et al. SUMOylation and deacetylation affect NF-κB p65 activity induced by high glucose in human lens epithelial cells[J]. Int J Ophthalmol, 2019, 12:1371-1379.
[15]Zhong XX, Wang W, Mao ZC, et al. Activation of liver x receptors prevents the spinal LTP induced by skin/muscle retraction in the thigh via SIRT1/NF-Κb pathway[J]. Neurochem Int, 2019, 128:106-114.